Page last updated: 2024-08-25

zoledronic acid and Cancer-Associated Pain

zoledronic acid has been researched along with Cancer-Associated Pain in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Bourlon, C; Bourlon, MT; Carretero-Gonzalez, A; Carril-Ajuria, L; Castellano, D; de Velasco, G; Martin-Soberon, M; Remolina-Bonilla, YA	1
Chen, F; Pu, F	1

Reviews

1 review(s) available for zoledronic acid and Cancer-Associated Pain

Article	Year
Safety of Denosumab Versus Zoledronic Acid in Patients with Bone Metastases: A Meta-Analysis of Randomized Controlled Trials. Oncology research and treatment, 2016, Volume: 39, Issue:7-8 Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Cancer Pain; Causality; Comorbidity; Denosumab; Diphosphonates; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Female; Humans; Imidazoles; Male; Patient Safety; Prevalence; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Zoledronic Acid	2016

Article

Year

Safety of Denosumab Versus Zoledronic Acid in Patients with Bone Metastases: A Meta-Analysis of Randomized Controlled Trials.

Oncology research and treatment, 2016, Volume: 39, Issue:7-8

Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Cancer Pain; Causality; Comorbidity; Denosumab; Diphosphonates; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Female; Humans; Imidazoles; Male; Patient Safety; Prevalence; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Zoledronic Acid

2016

Other Studies

1 other study(ies) available for zoledronic acid and Cancer-Associated Pain

Article	Year
Challenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 Pandemic. Oncology (Williston Park, N.Y.), 2020, 08-12, Volume: 34, Issue:8 Topics: Aged; Androgen Antagonists; Androstenes; Anticoagulants; Antineoplastic Agents; Betacoronavirus; Bone Density Conservation Agents; Bone Neoplasms; Cancer Pain; Coronavirus Infections; COVID-19; Disease Progression; Docetaxel; Drug Combinations; Eligibility Determination; Heparin, Low-Molecular-Weight; Humans; Intensive Care Units; Lopinavir; Male; Oxygen Inhalation Therapy; Palliative Care; Pandemics; Pneumonia, Viral; Prostatic Neoplasms, Castration-Resistant; Renal Insufficiency; Respiratory Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; Ritonavir; SARS-CoV-2; Severity of Illness Index; Zoledronic Acid	2020

Article

Year

Challenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 Pandemic.

Oncology (Williston Park, N.Y.), 2020, 08-12, Volume: 34, Issue:8

Topics: Aged; Androgen Antagonists; Androstenes; Anticoagulants; Antineoplastic Agents; Betacoronavirus; Bone Density Conservation Agents; Bone Neoplasms; Cancer Pain; Coronavirus Infections; COVID-19; Disease Progression; Docetaxel; Drug Combinations; Eligibility Determination; Heparin, Low-Molecular-Weight; Humans; Intensive Care Units; Lopinavir; Male; Oxygen Inhalation Therapy; Palliative Care; Pandemics; Pneumonia, Viral; Prostatic Neoplasms, Castration-Resistant; Renal Insufficiency; Respiratory Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; Ritonavir; SARS-CoV-2; Severity of Illness Index; Zoledronic Acid

2020